Zepbound bests Wegovy for weight loss in new trial
by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a
Updated on: December 18,2024
0
Zepbound bests Wegovy for weight loss in new trial
by Robin FosterZepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly."Given the increased interest a
Updated on:December 18,2024
0
